Lobar pneumonia caused by Ralstonia pickettii in a sixty-five-year-old Han Chinese man: a case report by Pan, Wensen et al.
CASE REPORT Open Access
Lobar pneumonia caused by Ralstonia pickettii in




2* and Mei Dong
3
Abstract
Introduction: Ralstonia pickettii is a gram-negative, oxidase-positive bacillus and is an emerging pathogen found in
infections described in hospital settings. The cases reported in the literature mostly are nosocomial infections due
to contaminated blood products, sterile water, saline, treatment fluids and venous catheters. Human infection
unrelated to contaminated solutions is rare. We report a case of lobar pneumonia and pulmonary abscess caused
by Ralstonia pickettii in an older patient.
Case presentation: A sixty-five-year old Han Chinese man presented having had cough, expectoration, chest pain
and fever lasting for twenty days. His medical history was notable for hypertension over the previous ten years,
and the habit of smoking for forty years. A thoracic computed tomography scan supported the diagnosis of right-
sided lobar pneumonia. A lung biopsy was done and pathological analysis confirmed lobar pneumonia. Two lung
biopsy specimens from separate sites grew Ralstonia pickettii. After six days, a repeat thoracic scan revealed a right-
sided abscess. A thoracentesis was performed and the purulent fluid grew Ralstonia pickettii. The chest tube
remained inserted to rinse the cavity with sterile sodium chloride. He received an antibiotic course of intravenous
cefoperazone sodium-sulbactam sodium for eighteen days and imipenem-cilastatin for twelve days. A repeat chest
X-ray revealed resolution of the pulmonary abscess and improvement of pneumonia. He remained afebrile and
free of respiratory symptoms after treatments.
Conclusion: This case demonstrates a Ralstonia pickettii infection in the absence of an obvious nosocomial source.
It is possible that such cases will become common in the future. Therefore, further studies are needed to evaluate
its sensitivity to common antibiotics.
Introduction
Ralstonia pickettii (R. pickettii) is an emerging pathogen.
It is ubiquitous in nature and is found naturally in soil
and groundwater. R. pickettii was first isolated in 1973
and included in the genus Pseudomonas [1]. The rod-
shaped organism was reclassified in the Burkholderia
and then the Ralstonia genera, receiving its current
name in 1995 [2]. R. pickettii is often confused with
other similar bacteria, increasing the difficulty of classi-
fying and treating this pathogen.
R. pickettii can be isolated from various clinical speci-
mens, such as sputum, blood, infected wounds, urine,
ear, nose swabs, and cerebrospinal fluid. It is also com-
monly found in the respiratory tract secretions of cystic
fibrosis patients. Most infections with R. pickettii are
seen in the hospital setting resulting in bacteremia and/
or septicemia and respiratory infections and/or pneumo-
nia [3]. The cases reported in the literature are mostly
nosocomial infections due to contaminated solutions
including blood products, sterile water, saline, chlorhexi-
dine solution, treatment fluids for the respiratory tract,
and contaminated venous catheters [4-7]. Human infec-
tion unrelated to contaminated solutions is rare. There
is only one documented case of an empyema caused by
R. pickettii, and our case is similar in some respects [8].
Our case is perhaps the first one reported of a lobar
pneumonia and pulmonary abscess caused by R.
pickettii.
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A sixty-five-year old Han Chinese man presented with
cough, expectoration, chest pain and fever lasting twenty
days to the emergency room. His medical history was
notable for hypertension over the previous ten years,
and a forty-year smoking history (20 cigarettes per day).
He did not have previous exposure to respiratory ther-
apy solutions and had not taken any antimicrobial
agents in the past five years. Pleuritic chest pain was the
most prominent symptom. The cough was dry initially,
but about five days later became productive. He had a
sudden onset of a high fever to 39°C, which resulted in
rigors. Upon initial presentation, he received antibiotic
therapy of intravenous penicillin sodium for seven days,
lavo-ofloxacin for five days and cefotaxime sodium for
seven days in turn, but his symptoms did not improve,
resulting in admission to our hospital.
His initial physical examination upon admission
revealed a temperature of 38.8°C; blood pressure, 120/85
mmHg; respiratory rate, 23 breaths per minute; and
pulse, 90 beats per minute. Evaluation for a source of
the fever demonstrated a right-sided lobar pneumonia
on chest X-ray. A thoracic computed tomography (CT)
scan supported the diagnosis of right-sided lobar pneu-
monia (Figure 1). Subsequently, a CT-guided lung
biopsy was done, which confirmed it to be lobar pneu-
monia in the period of gray hepatization (Figure 2). Two
biopsy specimens from separate sites grew R. pickettii in
pure cultures, which was identified by the API 20NE
system (bioMérieux France, No.0041445). He received
an antibiotic course of intravenous cefepime for six
days. A repeat thoracic CT scan revealed the presence
of a right-sided abscess (Figure 3). A centesis was
performed and the purulent fluid grew R. pickettii.T h e
chest tube placed for drainage remained in the cavity of
the abscess for rinsing with sterile sodium chloride solu-
tion. Because the pathogen had not responded to two
antibiotic treatments, its antimicrobial susceptibilities
were studied by the disk diffusion method of the Clini-
cal and Laboratory Standards Institute (CLSI) (9). The
breakpoints used to determine resistance and
Figure 1 Computed tomography scan (GE Medical System.
lightspeed 16) of the thorax showing features of lobar
pneumonia. In this image right lung lower lobe soft tissue density
shadow can be seen.
Figure 2 Lung biopsy appearance of lobar pneumonia-like
changes of the gray phase of liver. It is showing that alveolar
space is clearly visible, a large number of cellulose can be seen
seeping into cavity to form a network and through Trichoderma
Kong mutual links with the neighboring alveolar space.
(hematoxylin and eosin, magnification ×40).
Figure 3 Computed tomography scan of the thorax.T h es c a n
shows features typical of pulmonary abscesses, consolidation with a
single cavity containing an air-fluid level in the right lung after six
days of intravenous cefepime treatment.
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neously (Table 1). In this case, the R. pickettii isolate
was susceptible to cefoperazone sodium-sulbactam
sodium, ceftazidime, and imipenem according to the
disk diffusion method. The pathogen was resistant to
amikacin, ceftriaxone, ciprofloxacin, mezlocillin, aztreo-
nam, and gentamicin. Our patient received an antibiotic
course of intravenous cefoperazone sodium-sulbactam
sodium for eighteen days and imipenem-cilastatin for
twelve days. A repeat chest X-ray performed forty-eight
days later revealed resolution of the pulmonary abscess
and improvement of pneumonia. The patient remained
afebrile and free of respiratory symptoms at follow-up
two months later.
Discussion
Human infection with R. pickettii without exposure to
contaminated solutions is rare and isolation of the
organism in culture alone is often attributed to labora-
tory contamination rather than to infection. Therefore,
infection with R. pickettii is typically diagnosed when
treatment targeting the organism and/or removal of an
infected source is associated with clinical improvement.
For example, a recently reported case of R. pickettii
infection in a pediatric oncology unit described clinical
improvement only with catheter removal and appropri-
ate antimicrobial therapy [10]. In this case, isolation of
R. pickettii in culture from a sterile site coupled with
clinical improvement following thoracentesis and tar-
geted antimicrobial therapy increases the likelihood that
t h eo r g a n i s mw a st h ep a t h o g e n i cs o u r c e .I no u rc a s e ,
there had been no use of respiratory therapy solutions
excluding the possibility of exposure to fluids contami-
nated with R. pickettii.
R. pickettii is generally believed not to be the pri-
mary pathogen and, alone, its infectivity is very low.
Recent reports show that it can lead to a number of
potentially serious infections, nosocomial outbreaks
[4,11] and even death [3]. Antimicrobial susceptibility
patterns reported for R. pickettii vary widely. R.
pickettii can produce extended-spectrum b-lactamases,
which are not commonly sensitive to inhibitors of b-
lactamase [12-15]. They show that the organism is
resistant in different degrees to ciprofloxacin, tri-
methoprim-pyrimidine, sulfamethoxazole, piperacillin-
tazobactam, imipenem and cilastatin, ceftazidime. Fol-
lowing susceptibility studies, our patient was success-
fully treated with intravenous cefoperazone sodium-
sulbactam sodium for eighteen days and imipenem-
cilastatin for twelve days.
Conclusion
We describe the case of an older man who developed R.
pickettii infection in the absence of an obvious nosoco-
mial source demonstrating the possibility that such de
novo cases will become more common in the future.
Although it is of low virulence, it has been identified as
causing many potentially harmful infections, and even
death. The pathogen was resistant to many antibiotics,
so its sensitivity to the common antibiotics should be
monitored regularly.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviations
CLSI: Clinical and Laboratory Standards Institute; CT: computed tomography;
R. Pickettii: Ralstonia pickettii.
Acknowledgements
We thank Baofa Wang, Yadong Yuan (Hebei Medical University), Jessica A.
Hennessey and Chuan Wang (Duke University Medical Center) for helping in
writing this manuscript.
Author details
1Department of Respiratory Medicine, the Second Hospital of Hebei Medical
University, Shijiazhuang, China.
2Department of Reproductive Medicine, the
Second Hospital of Hebei Medical University, Shijiazhuang, China.
3Department of Internal Medicine, the Affiliated Hospital of Hebei University
of Science and Technology, Shijiazhuang, China.
Table 1 Breakpoints used to determine resistance and susceptibility to antimicrobial therapy
Antimicrobial Agent Disk Content Zone Diameter Breakpoints, nearest whole mm
SIR
mezlocillin 75 μg ≧ 16 - ≦ 15
ceftazidime 30 μg ≧ 18 15-17 ≦ 14
cefoperazone 75 μg ≧ 21 16-20 ≦ 15
ceftriaxone 30 μg ≧ 21 14-20 ≦ 13
imipenem 10 μg ≧ 16 14-15 ≦ 13
aztreonam 30 μg ≧ 22 16-21 ≦ 15
gentamicin 10 μg ≧ 15 13-14 ≦ 12
ciprofloxacin 5 μg ≧ 21 16-20 ≦ 15
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